Tanalys

mHospitals are now being launched in several countries – expected to meet 500 cardiac consultations in 90 days

VBRI, a Swedish/Indian company that offers innovation services within the technology and health sectors as well as other industries, has just launched the field trial version of virtual hospital platform – mHospitals – at its four different centers in China, India and Sweden. It will start as a virtual cardiac platform that will serve patients suffering from cardiovascular diseases. In time more countries will be connected, and the number of services will grow.

By utilizing advanced technologies like cloud medicine, machine learning and artificial intelligence, the mHospitals platform will provide the best quality of cardiac care to the patients along with the ultimate level of convenience. mHospitals patients will be able to access secure cardiac care rights in their home without having to travel an inch

– Being from a village in India, I have witnessed how people had to struggle and travel long distance to access secure healthcare. In 2014, when I was attending a conference in rural parts of India, my mother got ill. From that day I started working towards where we are today with the release of the mHospitals, it is like a dream that has come true. It is our sincere hope that our attempt to amalgamate cloud medicine IoT, Machine Learning and AI and connect it to smart wearable healthcare devices, that we are on our way to bring down barriers like time and distance from the world of cardiac care, says Dr. Ashutosh Tiwari, Managing Director of VBRI, who was present in VBRI’s office in China during today’s launch.

Dr. Yogesh Shukla, director of mHospitals, was present at the VBRI office in Prayagraj, India, during the launch of mHospitals.
– The platform has gone through an extensive range of field trials and the results have been successful. So far, we have provided consultancy to patients and also started performing surgeries. With the wide network of world class doctors and specialists, mHospitals, after the completion of field trials, will surely be ready to provide extensive cardiac care to patients. Now in this 6th stage of field trials, we aim to provide cardiac consultancy to 500 patients in the upcoming 90 days. We will not attend any medical emergency at this stage, he says

Pavan Pandey, the director of IT at VBRI Innovation centre in New Delhi, India believes that the mHospitals will see a bright future:
– mHospitals is a classic example of the perfect fusion of medical expertise and advanced new-age technologies for the betterment of society. The platform has made optimum use of technologies like Machine Learning, IoT and AI to make sure that the patients get instant and quality healthcare at their doorstep. Further, he said that the product will surely be extremely helpful for the Indian population through our in-house developed unique database management system.

Dr. Mikael Syväjärvi, one of the Swedish Scientist attended the launch ceremony at VBRI Sverige AB, Sweden, concurs with Pavan Pandey:
– mHospitals is the result of advanced Swedish technology and contains all the advanced features that one can except from a virtual hospitals platform. All the cutting-edge technologies have been implemented to ensure a good experience for the patients using it. By employing Machine Learning, IoT and AI, we have made sure that the platform us user friendly and provides the patients with a quality experience.

Dr. Ashutosh Tiwari also expressed his regards for the team that is responsible for the design and development of the mHospitals. he further said that he hopes that mHospitals leads a successful road ahead to achieve its goals effectively.

For more information about the mHospitals, visit:
www.mhospitals.com
www.vbrigroup.com

For further information please contact:
Dr Ashutosh Tiwari, founder VBRI Group, tfn: +46 (0)725 44 55 53, e-mail: md@vbrigroup.com
Anders Ekhammar, press contact VBRI Group, tfn: +46 (0)707 46 25 79, e-mail: anders.ekhammar@perspective.se

Taggar:

Exit mobile version